Literature DB >> 8416557

Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.

S A Mirowitz1, J J Brown, J P Heiken.   

Abstract

Thirteen patients who underwent subsequent radical prostatectomy for prostate cancer were studied with spin-density-T2-weighted and gadolinium-enhanced and unenhanced T1-weighted magnetic resonance (MR) imaging performed with an endorectal surface coil. With gadopentetate dimeglumine, the central gland showed inhomogeneous enhancement due to benign hyperplasia, whereas the peripheral zone demonstrated more uniform and less intense enhancement. With the T1-weighted sequence, depiction of the zonal anatomy, prostate capsule, surgical capsule, fibromuscular stroma, and periprostatic venous plexus was better with contrast enhancement, but these were best demonstrated on T2-weighted images. The trend was similar for prostatic tumor extent and capsular integrity. The seminal vesicles had a septal enhancement pattern and in several patients were best evaluated with enhanced T1-weighted images. These findings suggest that gadopentetate dimeglumine is not warranted for routine use in endorectal MR imaging of the prostate but may be useful for evaluation of the seminal vesicles in selected patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416557     DOI: 10.1148/radiology.186.1.8416557

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Authors:  Tobias Franiel; Bernd Hamm; Hedvig Hricak
Journal:  Eur Radiol       Date:  2010-12-24       Impact factor: 5.315

2.  Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens.

Authors:  C Bartolozzi; I Menchi; R Lencioni; S Serni; A Lapini; G Barbanti; A Bozza; A Amorosi; A Manganelli; M Carini
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging.

Authors:  R Lencioni; I Menchi; A Paolicchi; M Carini; A Amorosi; C Bartolozzi
Journal:  MAGMA       Date:  1997-06       Impact factor: 2.310

4.  Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging.

Authors:  P J Haggett; N R Moore; J D Shearman; S P Travis; D P Jewell; N J Mortensen
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

5.  Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

Authors:  Tracy W Liu; Thomas D Macdonald; Cheng S Jin; Joseph M Gold; Robert G Bristow; Brian C Wilson; Gang Zheng
Journal:  ACS Nano       Date:  2013-04-05       Impact factor: 15.881

6.  Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.

Authors:  A Latifoltojar; N Dikaios; A Ridout; C Moore; R Illing; A Kirkham; S Taylor; S Halligan; D Atkinson; C Allen; M Emberton; S Punwani
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

Review 7.  MRI in prostate cancer.

Authors:  Mahyar Ghafoori; Manijeh Alavi; Mounes Aliyari Ghasabeh
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.